Expertise in
13
conditions

Dr. Carl J. Pepine

Cardiology
Uf Health Sports And Exercise Cardiology-Springhill
4037 NW 86th Ter Fl 2, 
Gainesville, FL 
Accepting New Patients
Referral may be required
Before you request
Expertise in
13
conditions
Uf Health Sports And Exercise Cardiology-Springhill
4037 NW 86th Ter Fl 2, 
Gainesville, FL 

Overview

Carl Pepine is a Cardiologist practicing medicine in Gainesville, Florida.

Dr. Pepine is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Angina, Coronary Heart Disease, Hypertension, Bone Marrow Aspiration, and Percutaneous Coronary Intervention (PCI).

He is actively involved in clinical research, co-authoring 465 peer reviewed articles and participating in 10 clinical trials. Dr. Pepine is currently accepting new patients.

Specialties

Cardiology

Licenses

Internal Medicine in FL

Hospital Affiliations

Uf Health Shands Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Florida Blue
  • EPO
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 3 Less Insurance Carriers -

Locations

Uf Health Sports And Exercise Cardiology-Springhill
4037 NW 86th Ter Fl 2, Gainesville, FL 32606

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
Enrollment Status: Active_not_recruiting
Publish Date: May 29, 2026
Intervention Type: Drug, Behavioral
Study Drugs: Statin, Lisinopril, Losartan, Aspirin
Study Phase: Phase 4
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1
Enrollment Status: Completed
Publish Date: March 23, 2026
Intervention Type: Biological, Other
Study Phase: Phase 3
Gut Inflammation and Gut-Gut Microbiome Interactions in the Pathogenesis of Hypertension
Gut Inflammation and Gut-Gut Microbiome Interactions in the Pathogenesis of Hypertension
Enrollment Status: Completed
Publish Date: September 29, 2025
Intervention Type: Other
Randomized Controlled Pivotal Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients With Ischemic Heart Failure (CardiAMP Heart Failure Trial)
Randomized Controlled Pivotal Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients With Ischemic Heart Failure (CardiAMP Heart Failure Trial)
Enrollment Status: Completed
Publish Date: September 19, 2025
Intervention Type: Other, Biological
Study Drug: Autologous Cell Therapy
Study Phase: Phase 3
The Role of Gut Microbiota in Hypertension: Brain-Gut Microbiome-Immune Axis in Hypertension
The Role of Gut Microbiota in Hypertension: Brain-Gut Microbiome-Immune Axis in Hypertension
Enrollment Status: Completed
Publish Date: August 17, 2025
Intervention Type: Other
Characterize the Gut Microbiota in Subjects With Heart Failure and Pre-heart Failure With Preserved Ejection Fraction
Characterize the Gut Microbiota in Subjects With Heart Failure and Pre-heart Failure With Preserved Ejection Fraction
Enrollment Status: Withdrawn
Publish Date: April 10, 2025
Intervention Type: Other
Phase 1 Study of Mesenchymal Stromal Cells, Umbilical Cord Lining Stem Cells (ULSC), in Patients With Polymyositis (PM) and Dermatomyositis (DM)
Phase 1 Study of Mesenchymal Stromal Cells, Umbilical Cord Lining Stem Cells (ULSC), in Patients With Polymyositis (PM) and Dermatomyositis (DM)
Enrollment Status: Completed
Publish Date: January 24, 2025
Intervention Type: Drug
Study Drug: Umbilical Cord Lining Stem Cells
Study Phase: Early Phase 1
Randomized, Double-Blind, Placebo-Controlled Phase I/II Study of the Safety and Efficacy of Intracoronary Delivery of Allogeneic Cardiosphere-Derived Cells in Patients With a Myocardial Infarction and Ischemic Left Ventricular Dysfunction
Randomized, Double-Blind, Placebo-Controlled Phase I/II Study of the Safety and Efficacy of Intracoronary Delivery of Allogeneic Cardiosphere-Derived Cells in Patients With a Myocardial Infarction and Ischemic Left Ventricular Dysfunction
Enrollment Status: Terminated
Publish Date: April 09, 2024
Intervention Type: Biological, Drug
Study Phase: Phase 1/Phase 2
A Phase II, Randomized, Placebo-Controlled Study of the Safety, Feasibility, & Efficacy of Autologous Mesenchymal Stem Cells & C-kit+ Cardiac Stem Cells, Alone or in Combination, Administered Transendocardially in Subjects With Ischemic HF
A Phase II, Randomized, Placebo-Controlled Study of the Safety, Feasibility, & Efficacy of Autologous Mesenchymal Stem Cells & C-kit+ Cardiac Stem Cells, Alone or in Combination, Administered Transendocardially in Subjects With Ischemic HF
Enrollment Status: Completed
Publish Date: April 26, 2021
Intervention Type: Biological
Study Phase: Phase 2
A Phase I, First-in-Human, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of the Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Cancer Survivors With Anthracycline-Induced Cardiomyopathy
A Phase I, First-in-Human, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of the Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Cancer Survivors With Anthracycline-Induced Cardiomyopathy
Enrollment Status: Completed
Publish Date: November 05, 2020
Intervention Type: Biological
Study Phase: Phase 1
View 9 Less Clinical Trials

465 Total Publications

Novel Home-Based Remotely Supervised High Intensity Interval Training is Safe and Feasible and Improves Aerobic Fitness and Adiposity in Older Adults.
Novel Home-Based Remotely Supervised High Intensity Interval Training is Safe and Feasible and Improves Aerobic Fitness and Adiposity in Older Adults.
Journal: Medicine and science in sports and exercise
Published: August 06, 2026
Similar Doctors
Expertise in
9
conditions
Expertise in
9
conditions
Referral may be required
Before you request

Uf Health Cardiology-Springhill

4037 NW 86th Ter, 
Gainesville,, FL 
 (0.1 miles away)
352-265-0820
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Arwa Saidi is a Cardiologist practicing medicine in Gainesville,, Florida. Dr. Saidi is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Congenital Heart Disease (CHD), Tetralogy of Fallot, Transposition of the Great Arteries, and Partial Atrioventricular Canal. Dr. Saidi is currently accepting new patients.

Expertise in
22
conditions
Expertise in
22
conditions
Referral may be required
Before you request

Uf Health Medical Lab-Shands Hospital

1600 SW Archer Rd, 
Gainesville, FL 
 (6.5 miles away)
352-392-2469
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Anthony Bavry is a Cardiologist practicing medicine in Gainesville, Florida. Dr. Bavry is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Aortic Valve Stenosis, Coronary Heart Disease, Heart Attack, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR). Dr. Bavry is currently accepting new patients.

Expertise in
13
conditions
Dr. Mustafa M. Ahmed
Cardiology | Advanced Heart Failure and Transplant Cardiology
Expertise in
13
conditions
Dr. Mustafa M. Ahmed
Cardiology | Advanced Heart Failure and Transplant Cardiology
Referral may be required

Florida Clinical Practice Association Inc

1600 Sw Archer Rd, Occupational Medicine At Shands Uf, 
Gainesville, FL 
 (6.5 miles away)
352-294-5700
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Mustafa Ahmed is a Cardiologist and an Advanced Heart Failure and Transplant Cardiologist practicing medicine in Gainesville, Florida. Dr. Ahmed is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Heart Failure, Cardiomyopathy, Pulmonary Edema, Heart Transplant, and Embolectomy. Dr. Ahmed is currently accepting new patients.

Frequently Asked Questions about Dr. Carl J. Pepine

How do I make an appointment with Dr. Carl J. Pepine?

You can book an appointment with Dr. Carl J. Pepine by calling their office at 352-627-4293. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Carl J. Pepine a top-rated expert for Angina?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Carl J. Pepine is classified as an Elite expert for Angina, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Carl J. Pepine specialize in?

While Dr. Carl J. Pepine is a Cardiology, they have specific expertise in Angina, Coronary Heart Disease, and Hypertension. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Cardiology.

Does Dr. Carl J. Pepine participate in research or clinical trials?

Yes. Dr. Carl J. Pepine has published 465 articles and abstracts on conditions like Angina. You can view a list of Dr. Carl J. Pepine's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Carl J. Pepine accept my insurance?

Dr. Carl J. Pepine accepts most major insurance plans, including Blue Cross Blue Shield and Florida Blue. We recommend calling the office directly at 352-627-4293 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Pepine's expertise for a condition
ConditionClose
View All 26 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile